Gert de Vos is a Dutch inventor, active in the biomedical field. Gert holds degrees in Biology and Physics from Leiden University.
He started Molecular Biology Systems (MBS) in The Netherlands in 2015 to develop the ultrafast NextGenPCR technology and serves as CEO of MBS.
In the past, Gert has been active in the field of DGGE and 2D-DGGE.
Gert’s field of interest currently covers ultra fast PCR and sleep apnea.
In sleep apnea he has been involved in the development of an alternative treatment of this condition, using an earplug to stimulate the brain stem electrically from a point on the ear.
In MBS Gert is responsible for the development of his invention into a product that can be used in the majority of labs. This also explains the choice to work with a microtiter plate format. With the MBS development, PCR has become significantly faster. The system developed in MBS is the first system in the world, taking the microtiter plate format to such a speed, that it challenges all existing enzymes. The machine is now no longer the limiting factor.
Gert holds patents in several biomedical fields, including PCR-instrumentation.